Mougari, S., Favède, V., Predella, C., Reynard, O., Durand, S., Mazelier, M., Pizzioli, E., Decimo, D., Bovier, F. T., Lapsley, L. M., Castagna, C., Lieberman, N. A. P., Noel, G., Mathieu, C., Malissen, B., Briese, T., Greninger, A. L., Alabi, C. A., Dorrello, N. V., … Horvat, B. (2025). Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity. Communications Biology, 8(1). https://doi.org/10.1038/s42003-025-07491-4

Zidar, D. A., Wilson, B. M., Al-Kindi, S. G., Sweet, D., Juchnowski, S., Huntington, L., Shive, C., Bosch, J., King, C., Karn, J., Chung, M. K., Gillombardo, C. B., Karnib, M., Sundaram, V., Parikh, S. A., Jain, M., Gunzler, D. D., Skarbinski, J., Tang, W. H. W., … Dalton, J. E. (2024). Pre-exposure immunohematologic features of heart failure associate with COVID-19 mortality. Npj Cardiovascular Health, 1(1). https://doi.org/10.1038/s44325-024-00025-7

Saiman, L., Walsh, E. E., Branche, A. R., Barrett, A., Alba, L., Gollerkeri, S., Schillinger, J. A., Phillips, M., & Finelli, L. (2024). Impact of Age and Comorbid Conditions on Incidence Rates of COVID‐19‐Associated Hospitalizations, 2020–2021. Influenza and Other Respiratory Viruses, 18(11). Portico. https://doi.org/10.1111/irv.70016

Siegal, D. M., Tseng, E. K., Schünemann, H. J., Angchaisuksiri, P., Cuker, A., Dane, K. E., DeSancho, M. T., Diuguid, D. L., Griffin, D. O., Klok, F. A., Lee, A. I., Neumann, I., Pai, A., Righini, M., Sanfilippo, K., Terrell, D. R., Akl, E. A., Al Jabiri, R. N., Al Jabiri, Y. N., … Nieuwlaat, R. (2024). ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014219

Janes, H., Fisher, L. H., Kee, J. J., Parameswaran, L., Goepfert, P. A., Falsey, A. R., Ludwig, J., Magaret, C. A., Gilbert, P. B., Kublin, J. G., Rouphael, N., Sobieszczyk, M. E., El Sahly, H. M., Baden, L. R., Grinsztejn, B., Walsh, S. R., Gray, G. E., Kotloff, K. L., Gay, C. L., … Huang, Y. (2024). Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae400

Kota, K. P., Trakht, I., Kalantarov, G., Ordonez, D., Wei, J., Trefry, S., Bavari, E., Richardson, J., Zamani, R., Raney, C., Nasar, F., Daugherty, B., Lederman, S., & Bavari, S. (2024). High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant Neutralization. Microorganisms, 12(8), 1503. https://doi.org/10.3390/microorganisms12081503

Francoeur, C., Alcamo, A. M., Robertson, C. L., Wainwright, M. S., Roa, J. D., Lovett, M. E., Stulce, C., Yacoub, M., Potera, R. M., Zivick, E., Holloway, A., Nagpal, A., Wellnitz, K., Even, K. M., Brunow de Carvalho, W., Rodriguez, I. S., Schwartz, S. P., Walker, T. C., … Campos-Miño, S. (2024). Severe Pediatric Neurological Manifestations With SARS-CoV-2 or MIS-C Hospitalization and New Morbidity. JAMA Network Open, 7(6), e2414122. https://doi.org/10.1001/jamanetworkopen.2024.14122

Coleman, B., Casiraghi, E., Callahan, T. J., Blau, H., Chan, L. E., Laraway, B., Clark, K. B., Re’em, Y., Gersing, K. R., Wilkins, K. J., Harris, N. L., Valentini, G., Haendel, M. A., Reese, J. T., & Robinson, P. N. (2024). Association of post-COVID phenotypic manifestations with new-onset psychiatric disease. Translational Psychiatry, 14(1). https://doi.org/10.1038/s41398-024-02967-z

McGroder, C. F., Salvatore, M. M., D’Souza, B. M., Hoffman, E. A., Baldwin, M. R., & Garcia, C. K. (2024). Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection. Thorax, 79(5), 472–475. https://doi.org/10.1136/thorax-2023-220370

Griggs, E. P., Mitchell, P. K., Lazariu, V., Gaglani, M., McEvoy, C., Klein, N. P., Valvi, N. R., Irving, S. A., Kojima, N., Stenehjem, E., Crane, B., Rao, S., Grannis, S. J., Embi, P. J., Kharbanda, A. B., Ong, T. C., Natarajan, K., Dascomb, K., Naleway, A. L., … Tenforde, M. W. (2023). Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023. Clinical Infectious Diseases, 78(2), 338–348. https://doi.org/10.1093/cid/ciad505

Souza, M. S., Farias, J. P., Andreata‐Santos, R., Silva, M. P., Brito, R. D. da S., Duarte Barbosa da Silva, M., Peter, C. M., Cirilo, M. V. de F., Luiz, W. B., Birbrair, A., Vidal, P. O., de Castro‐Amarante, M. F., Candido, E. D., Munhoz, A. S., de Mello Malta, F., Dorlass, E. G., Machado, R. R. G., Pinho, J. R. R., Oliveira, D. B. L., … Amorim, J. H. (2024). Neutralizing antibody response after immunization with a COVID‐19 bivalent vaccine: Insights to the future. Journal of Medical Virology, 96(2). Portico. https://doi.org/10.1002/jmv.29416

Pires Farias, J., Andreata-Santos, R., Dalety da Silva Brito, R., Silva Souza, M., Moreira Costa Fogaça, M., Ramos Pinheiro, J., Ferreira da Cruz, E., Liang, W., Simões, R. da C., Barros Luiz, W., Birbrair, A., Oliveira Vidal, P., Terzi Maricato, J., Torres Braconi, C., Ferreira, L. C. de S., Ramos Janini, L. M., & Amorim, J. H. (2023). The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population. Microbiology Spectrum, 11(6). https://doi.org/10.1128/spectrum.02857-23

Boruah, A. P., Thakur, K. T., Gadani, S. P., Kothari, K. U., Chomba, M., Guekht, A., Heydari, K., Hoo, F. K., Hwang, S., Michael, B. D., Pandit, M. V., Pardo, C. A., Prasad, K., Sardar, Z., Seeher, K., Solomon, T., Winkler, A. S., Wood, G. K., & Schiess, N. (2023). Pre-existing neurological conditions and COVID-19 co-infection: Data from systematic reviews, meta-analyses, and scoping reviews. Journal of the Neurological Sciences, 455, 120858. https://doi.org/10.1016/j.jns.2023.120858

Fusco, F., Krasuski, R. A., Sadeghi, S., Rosenbaum, M. S., Lewis, M. J., Carazo, M. R., Rodriguez, F. H., Halpern, D. G., Feinberg, J. L., Galilea, F. A., Baraona, F., Cedars, A. M., Ko, J. M., Porayette, P., Maldonado, J. R., Frogoudaki, A. A., Nir, A., Chaudhry, A., John, A. S., … Sarubbi, B. (2023). COVID-19–Related Thrombotic and Bleeding Events in Adults With Congenital Heart Disease. JACC: Advances, 2(10), 100701. https://doi.org/10.1016/j.jacadv.2023.100701

Ramlall, V., Gisladottir, U., Kefeli, J., Tanaka, Y., May, B., & Tatonetti, N. (2023). Using machine learning probabilities to identify effects of COVID-19. Patterns, 4(12), 100889. https://doi.org/10.1016/j.patter.2023.100889

Smith-Jeffcoat, S. E., Biddle, J. E., Talbot, H. K., Olivo, V., Sano, E., Goodman, S. H., Petrie, J., Ledezma, K. I., Bullock, A., Rao, S., Mellis, A., Johnson, S., Kirking, H. L., Rolfes, M. A., Zhu, Y., Schmitz, J., Hart, K. W., Battan-Wraith, S., Merrill, L. S., … Salvatore, P. P. (2023). 930. COVID-19 symptom and viral load rebound among individuals reporting nirmatrelvir/ritonavir use compared to propensity score matched individuals not taking COVID-19 treatment. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.975

Holodniy, M., Pei, Y., Stack, G., Wade, C. L., Agrawal, Y., Barasch, N., Baddoura, F., Carmen Frias-Kletecka, M., Stacey Klutts, J., & Wang-rodriguez, J. (2023). 2353. SARS-CoV-2 Variants among US Veterans after COVID-19 Bivalent Vaccine Administration. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.1974

Soni, M. K., Migliori, E., Fu, J., Assal, A., Chan, H. T., Pan, J., Khatiwada, P., Ciubotariu, R., May, M. S., Pereira, M. R., De Giorgi, V., Sykes, M., Mapara, M. Y., & Muranski, P. J. (2023). The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1212203

Xie, J., Kuppermann, N., Florin, T. A., Tancredi, D. J., Funk, A. L., Kim, K., Salvadori, M. I., Yock-Corrales, A., Shah, N. P., Breslin, K. A., Chaudhari, P. P., Bergmann, K. R., Ahmad, F. A., Nebhrajani, J. R., Mintegi, S., Gangoiti, I., Plint, A. C., Avva, U. R., Gardiner, M. A., … Freedman, S. B. (2023). Impact of SARS-CoV-2 Infection on the Association Between Laboratory Tests and Severe Outcomes Among Hospitalized Children. Open Forum Infectious Diseases, 10(10). https://doi.org/10.1093/ofid/ofad485

Sánchez-Rico, M., Edán-Sánchez, A., Olfson, M., Alvarado, J. M., Airagnes, G., Rezaei, K., Delcuze, A., Peyre, H., Limosin, F., & Hoertel, N. (2023). Antipsychotic use and 28-day mortality in patients hospitalized with COVID-19: A multicenter observational retrospective study. European Neuropsychopharmacology, 75, 93–104. https://doi.org/10.1016/j.euroneuro.2023.06.005

Blumberg, E. A., Nam, H. H., Covington, S., Danziger-Isakov, L., Kumar, D., Michaels, M. G., Razonable, R. R., & Pereira, M. R. (2023). Into the unknown: The end of the coronavirus disease 2019 public health emergency in the United States and potential impacts on organ transplant recipients. American Journal of Transplantation, 23(10), 1507–1510. https://doi.org/10.1016/j.ajt.2023.07.007

Zavala, S., DeLaurentis, C., Aaron, J. G., Miko, B. A., Fox, A. N., Bergelson, M., DeVore, A., Segovia, M. C., Wolfe, C. R., & Pereira, M. R. (2023). When you need to dive in the deep end—Transplanting SARS‐CoV‐2 PCR+ recipients. Transplant Infectious Disease, 25(5). Portico. https://doi.org/10.1111/tid.14110

Rybkina, K., Bell, J. N., Bradley, M. C., Wohlbold, T., Scafuro, M., Meng, W., Korenberg, R. C., Davis-Porada, J., Anderson, B. R., Weller, R. J., Milner, J. D., Moscona, A., Porotto, M., Luning Prak, E. T., Pethe, K., Connors, T. J., & Farber, D. L. (2023). SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19. Journal of Experimental Medicine, 220(8). https://doi.org/10.1084/jem.20221518

Embi, P. J., Levy, M. E., Patel, P., DeSilva, M. B., Gaglani, M., Dascomb, K., Dunne, M. M., Klein, N. P., Ong, T. C., Grannis, S. J., Natarajan, K., Yang, D.-H., Stenehjem, E., Zerbo, O., McEvoy, C., Rao, S., Thompson, M. G., Konatham, D., Irving, S. A., … Naleway, A. L. (2023). Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021. Vaccine, 41(37), 5424–5434. https://doi.org/10.1016/j.vaccine.2023.05.038

Theodore, D. A., Branche, A. R., Zhang, L., Graciaa, D. S., Choudhary, M., Hatlen, T. J., Osman, R., Babu, T. M., Robinson, S. T., Gilbert, P. B., Follmann, D., Janes, H., Kublin, J. G., Baden, L. R., Goepfert, P., Gray, G. E., Grinsztejn, B., Kotloff, K. L., Gay, C. L., … Leathers, V. (2023). Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults. JAMA Network Open, 6(7), e2323349. https://doi.org/10.1001/jamanetworkopen.2023.23349

Ren, J.-X., Gao, Q., Zhou, X.-C., Chen, L., Guo, W., Feng, K.-Y., Lu, L., Huang, T., & Cai, Y.-D. (2023). Identification of Gene Markers Associated with COVID-19 Severity and Recovery in Different Immune Cell Subtypes. Biology, 12(7), 947. https://doi.org/10.3390/biology12070947

Muntner, P., Foti, K., Wang, Z., Alanaeme, C. J., Choi, E., Bress, A. P., Shimbo, D., & Kronish, I. (2023). Discontinuation of Renin–Angiotensin System Inhibitors During the Early Stage of the COVID-19 Pandemic. American Journal of Hypertension, 36(7), 404–410. https://doi.org/10.1093/ajh/hpad027

Adams, K., Riddles, J. J., Rowley, E. A. K., Grannis, S. J., Gaglani, M., Fireman, B., Hartmann, E., Naleway, A. L., Stenehjem, E., Hughes, A., Dalton, A. F., Natarajan, K., Dascomb, K., Raiyani, C., Irving, S. A., Sloan-Aagard, C., Kharbanda, A. B., DeSilva, M. B., Dixon, B. E., … Tenforde, M. W. (2023). Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study. The Lancet Regional Health - Americas, 23, 100530. https://doi.org/10.1016/j.lana.2023.100530

Bozio, C. H., Butterfield, K. A., Briggs Hagen, M., Grannis, S., Drawz, P., Hartmann, E., Ong, T. C., Fireman, B., Natarajan, K., Dascomb, K., Gaglani, M., DeSilva, M. B., Yang, D.-H., Midgley, C. M., Dixon, B. E., Naleway, A. L., Grisel, N., Liao, I. C., Reese, S. E., … Stenehjem, E. (2023). Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance. The Journal of Infectious Diseases, 227(12), 1348–1363. https://doi.org/10.1093/infdis/jiad040

Sania, A., Mahmud, A. S., Alschuler, D. M., Urmi, T., Chowdhury, S., Lee, S., Mostari, S., Shaikh, F. Z., Sojib, K. H., Khan, T., Khan, Y., Chowdhury, A., & Arifeen, S. el. (2023). Risk factors for COVID-19 mortality among telehealth patients in Bangladesh: A prospective cohort study. PLOS Global Public Health, 3(6), e0001971. https://doi.org/10.1371/journal.pgph.0001971

Muri, J., Cecchinato, V., Cavalli, A., Shanbhag, A. A., Matkovic, M., Biggiogero, M., Maida, P. A., Moritz, J., Toscano, C., Ghovehoud, E., Furlan, R., Barbic, F., Voza, A., De Nadai, G., Cervia, C., Zurbuchen, Y., Taeschler, P., Murray, L. A., Danelon-Sargenti, G., … Robbiani, D. F. (2023). Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nature Immunology, 24(4), 604–611. https://doi.org/10.1038/s41590-023-01445-w

Link-Gelles, R., Levy, M. E., Natarajan, K., Reese, S. E., Naleway, A. L., Grannis, S. J., Klein, N. P., DeSilva, M. B., Ong, T. C., Gaglani, M., Hartmann, E., Dickerson, M., Stenehjem, E., Kharbanda, A. B., Han, J., Spark, T. L., Irving, S. A., Dixon, B. E., Zerbo, O., … Tenforde, M. W. (2023). Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods. JAMA Network Open, 6(3), e232598. https://doi.org/10.1001/jamanetworkopen.2023.2598

McLaughlin, L., Hennecken, C., Doulamis, I., Briasoulis, A., & Kampaktsis, P. (2023). INCREASING MORTALITY RATES FROM INFECTIVE ENDOCARDITIS AMONG YOUNG UNITED STATES RESIDENTS. Journal of the American College of Cardiology, 81(8), 1945. https://doi.org/10.1016/s0735-1097(23)02389-6

Farias, J. P., Pinheiro, J. R., Andreata‐Santos, R., Fogaça, M. M. C., da Silva Brito, R. D., da Cruz, E. F., de Castro‐Amarante, M. F., Pereira, S. S., dos Santos Almeida, S., Moreira, L. M., da Conceição Simões, R., Luiz, W. B., Birbrair, A., Belmok, A., Ribeiro, B. M., Maricato, J. T., Braconi, C. T., de Souza Ferreira, L. C., Janini, L. M. R., & Amorim, J. H. (2023). The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS‐CoV‐2 variant. Journal of Medical Virology, 95(2). Portico. https://doi.org/10.1002/jmv.28481

Reiken, S. R., Dridi, H., Sittenfeld, L., Liu, Y., & Marks, A. R. (2023). Molecular mechanisms of cardiac complications associated with COVID-19. Biophysical Journal, 122(3), 236a–237a. https://doi.org/10.1016/j.bpj.2022.11.1388

M, R. T. (2023). Viral Induced Coagulopathy: A Formidable Foe or a Benevolent Friend. Vaccines & Vaccination Open Access, 8(1), 1–4. https://doi.org/10.23880/vvoa-16000158

Kumar, A., Asghar, A., Singh, H. N., Faiq, M. A., Kumar, S., Narayan, R. K., Kumar, G., Dwivedi, P., Sahni, C., Jha, R. K., Kulandhasamy, M., Prasoon, P., Sesham, K., Kant, K., & Pandey, S. N. (2023). SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis. JMIR Bioinformatics and Biotechnology, 4, e42700. https://doi.org/10.2196/42700

Reese, J. T., Blau, H., Casiraghi, E., Bergquist, T., Loomba, J. J., Callahan, T. J., Laraway, B., Antonescu, C., Coleman, B., Gargano, M., Wilkins, K. J., Cappelletti, L., Fontana, T., Ammar, N., Antony, B., Murali, T. M., Caufield, J. H., Karlebach, G., McMurry, J. A., … Divers, J. (2023). Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine, 87, 104413. https://doi.org/10.1016/j.ebiom.2022.104413

Bakouny, Z., Labaki, C., Grover, P., Awosika, J., Gulati, S., Hsu, C.-Y., Alimohamed, S. I., Bashir, B., Berg, S., Bilen, M. A., Bowles, D., Castellano, C., Desai, A., Elkrief, A., Eton, O. E., Fecher, L. A., Flora, D., Galsky, M. D., Gatti-Mays, M. E., … Stratton, C. (2023). Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19. JAMA Oncology, 9(1), 128. https://doi.org/10.1001/jamaoncol.2022.5357

Burack, D., Pereira, M. R., & Verna, E. (2022). 2116. Long-term (2-year) outcomes and complications of COVID-19 in solid organ transplant (SOT) recipients. Open Forum Infectious Diseases, 9(Supplement_2). https://doi.org/10.1093/ofid/ofac492.1737

Liu, H., Iketani, S., Zask, A., Khanizeman, N., Bednarova, E., Forouhar, F., Fowler, B., Hong, S. J., Mohri, H., Nair, M. S., Huang, Y., Tay, N. E. S., Lee, S., Karan, C., Resnick, S. J., Quinn, C., Li, W., Shion, H., Xia, X., … Stockwell, B. R. (2022). Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-29413-2

Abramov, A., Su, I., Agerstrand, C., Flatley, M., Dubois, R., Feldhaus, D., Stanifer, B. P., Sonett, J., Brodie, D., & Lemaitre, P. (2022). Extracorporeal Membrane Oxygenation Support in COVID-19 Patients: A Propensity Score Analysis. ASAIO Journal, 68(12), e224–e229. https://doi.org/10.1097/mat.0000000000001829

Cabrera-Garcia, D., Miltiades, A., Yim, P., Parsons, S., Elisman, K., Mansouri, M. T., Wagener, G., & Harrison, N. L. (2022). Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients. International Journal of Hematology, 116(6), 937–946. https://doi.org/10.1007/s12185-022-03437-2

Zeijlon, R., Hällgren, P., Le, V., Chamat, J., Wågerman, J., Enabtawi, I., Rawshani, A., Unenge, S., Jha, S., Omerovic, E., & Redfors, B. (2022). The role of admission electrocardiogram in predicting outcome in patients hospitalized for COVID-19. Journal of Electrocardiology, 75, 10–18. https://doi.org/10.1016/j.jelectrocard.2022.10.005

Hedvat, J., Lange, N. W., Salerno, D. M., DeFilippis, E. M., Kovac, D., Corbo, H., Chen, J. K., Choe, J. Y., Lee, J. H., Anamisis, A., Jennings, D. L., Codispodo, G., Shertel, T., Brown, R. S., & Pereira, M. R. (2022). COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era. American Journal of Transplantation, 22(11), 2682–2688. https://doi.org/10.1111/ajt.17140

Miller, C. N., Althoff, K. N., Schlueter, D. J., Anton-Culver, H., Chen, Q., Garbett, S., Ratsimbazafy, F., Thomsen, I., Karlson, E. W., Cicek, M., Pinto, L. A., Malin, B. A., Ohno-Machado, L., Williams, C., Goldstein, D., Kouame, A., Ramirez, A., Gebo, K. A., & Schully, S. D. (2022). Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence. MSphere, 7(5). https://doi.org/10.1128/msphere.00257-22

Villalba, J. A., Hilburn, C. F., Garlin, M. A., Elliott, G. A., Li, Y., Kunitoki, K., Poli, S., Alba, G. A., Madrigal, E., Taso, M., Price, M. C., Aviles, A. J., Araujo-Medina, M., Bonanno, L., Boyraz, B., Champion, S. N., Harris, C. K., Helland, T. L., Hutchison, B., … Shih, A. R. (2022). Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine, 206(7), 857–873. https://doi.org/10.1164/rccm.202109-2150oc

Reading Turchioe, M., Ahmed, R., Masterson Creber, R., Axsom, K., Horn, E., Sayer, G., Uriel, N., Stein, K., & Slotwiner, D. (2022). Detecting early physiologic changes through cardiac implantable electronic device data among patients with COVID-19. Cardiovascular Digital Health Journal, 3(5), 247–255. https://doi.org/10.1016/j.cvdhj.2022.07.070

Sobieszczyk, M. E., Maaske, J., Falsey, A. R., Sproule, S., Robb, M. L., Frenck, R. W., Tieu, H.-V., Mayer, K. H., Corey, L., Neuzil, K. M., Tong, T., Brewinski Isaacs, M., Janes, H., Bansal, H., Edwards, L. M., Green, J. A., Kelly, E. J., Shoemaker, K., Takas, T., … Hirsch, and I. (2022). Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months. Journal of Clinical Investigation, 132(18). https://doi.org/10.1172/jci160565